Biotech Business - August 11, 2021
Almi Invest invests in Strike Pharma
Almi Invest will invest just over 2 million SEK in the newly founded Uppsala-based company Strike Pharma. As previously reported by NLS, an immunotherapeutic cancer vaccine delivery-platform has been developed at the SciLifeLab Drug Discovery and Development platform (DDD). The researchers will continue to develop the method within the framework of the newly started company, […]
Biotech Business - August 10, 2021
Toleranzia proposes directed share issue of 42 million SEK
The purpose of the share issue is to fund an enhanced clinical trial program that can shorten the development time and increase the commercial potential of the company’s drug candidate TOL2 – one of the company’s potentially curative treatments for severe autoimmune diseases. TOL2, is being developed to cure myasthenia gravis – an autoimmune nerve […]
Biotech Business - July 27, 2021
Anocca raises 47 million USD
Anocca has announced the closing of a USD 47 million (SEK 400 million) Series B financing to further advance the company’s industrialised cellular biology platform and progress its pipeline of TCR-T cellular therapies into Phase I/IIa clinical trials. The financing, led by advisor Danske Bank, brings together a group of investors, with Swedbank Robur Ny […]
Biotech Business - July 12, 2021
Amniotics raises SEK 60 million
Amniotics, a stem cell therapy company, has raised SEK 60 million through its recent listing on Nasdaq First North Growth Market. The offering was fully subscribed and attracted widespread interest from Swedish investment companies and family offices as well as the general public in Sweden, Norway and Finland, states the company in a press release. […]
Biotech Business - July 7, 2021
Bio-Me secures NOK 10 million
Bio-Me has raised NOK 10 million in a fully subscribed funding round. Both existing and new investors participated in the financing round, with new investors contributing the majority of the capital, states the company in a press release. “We are excited to move forward with our plans to achieve specific value-driving milestones that position PMP […]
Financing - July 5, 2021
Iconovo completes a directed share issue of 75 million SEK
The Issue was subscribed for by several new Swedish and international institutional investors, such as Alcur Fonder, FE Fonder and Humle Fonder, as well as several existing owners, such as Andra AP-fonden, Fjärde AP-fonden, Handelsbanken Fonder and Länsförsäkringar Fondförvaltning AB. The company intends to use the proceeds from the Issue for accelerating and value-creational development […]
